It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The cell cortex is a dynamic assembly formed by the plasma membrane and underlying cytoskeleton. As the main determinant of cell shape, the cortex ensures its integrity during passive and active deformations by adapting cytoskeleton topologies through yet poorly understood mechanisms. The spectrin meshwork ensures such adaptation in erythrocytes and neurons by adopting different organizations. Erythrocytes rely on triangular-like lattices of spectrin tetramers, whereas in neurons they are organized in parallel, periodic arrays. Since spectrin is ubiquitously expressed, we exploited Expansion Microscopy to discover that, in fibroblasts, distinct meshwork densities co-exist. Through biophysical measurements and computational modeling, we show that the non-polarized spectrin meshwork, with the intervention of actomyosin, can dynamically transition into polarized clusters fenced by actin stress fibers that resemble periodic arrays as found in neurons. Clusters experience lower mechanical stress and turnover, despite displaying an extension close to the tetramer contour length. Our study sheds light on the adaptive properties of spectrin, which participates in the protection of the cell cortex by varying its densities in response to key mechanical features.
The actin-spectrin meshwork constitutes a ubiquitous element of the cell cytoskeleton that may be organized in different architectures. Here, the authors observe in fibroblasts periodic arrays of spectrin only previously seen in neurons, and highlight their role in mechanically protecting the cell cortex.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 The AIRC Institute of Molecular Oncology, IFOM ETS, Milan, Italy (GRID:grid.7678.e) (ISNI:0000 0004 1757 7797)
2 University of California San Diego, Department of Mechanical and Aerospace Engineering, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
3 The AIRC Institute of Molecular Oncology, IFOM ETS, Milan, Italy (GRID:grid.7678.e) (ISNI:0000 0004 1757 7797); ETH Zürich, Laboratory of Applied Mechanobiology, Department for Health Sciences and Technology, Zürich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780)
4 The AIRC Institute of Molecular Oncology, IFOM ETS, Milan, Italy (GRID:grid.7678.e) (ISNI:0000 0004 1757 7797); IRCCS Humanitas Research Hospital, Humanitas Cardio Center, Rozzano (Milan, Italy (GRID:grid.417728.f) (ISNI:0000 0004 1756 8807)